We present a global panel dataset of COVID-19 vaccine policies, with data from 01 January 2020 for 185 countries and a number of sub-national jurisdictions, reporting on vaccination prioritisation plans, eligibility and availability, cost to the individual, and mandatory vaccination policies. For each of these indicators, we recorded who is targeted by a policy using 53 standardised categories. These indicators document a detailed picture of the unprecedented scale of global COVID-19 vaccination rollout and strategy, indicating which countries prioritised and vaccinated which groups, when, and in what order. We highlight key descriptive findings from these data, to demonstrate uses for the data and to encourage researchers and policy makers in future research and vaccination planning. Numerous patterns emerge. For example: some countries prioritised border workers and economic sectors (“eliminator” countries), while others prioritised the elderly and healthcare sectors for the first COVID-19 vaccinations (“mitigator” countries); High Income Countries (HICs) published prioritisation plans and began vaccinations earlier than Low- and Middle-Income Countries (LMICs). Fifty-five countries were found to have implemented at least one policy of mandatory vaccination. We also demonstrate the value of combining this data with vaccination uptake rates, vaccine supply and demand data, and with further COVID-19 epidemiological data. (200 words).
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.